Safety and Efficacy of Cryoballoon Ablation for Paroxysmal Atrial Fibrillation in Japan　– Results From the Japanese Prospective Post-Market Surveillance Study

Safety and Efficacy of Cryoballoon Ablation for Paroxysmal Atrial Fibrillation in Japan　– Results From the Japanese Prospective Post-Market Surveillance Study –

Published:2016 Issue:8 Volume:80 Page:1744-1749
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Okumura Ken¹,Matsumoto Kazuo²,Kobayashi Yoshinori³,Nogami Akihiko⁴,Hokanson Robert B⁵,Kueffer Fred⁵,

Affiliation:

1. Department of Cardiology, Hirosaki University Graduate School of Medicine

2. Division of Arrhythmia Treatment, Department of Cardiology, Saitama International Medical Center, Saitama Medical University

3. Division of Cardiology, Tokai University Hachioji - Hospital

4. Cardiovascular Division, Faculty of Medicine, University of Tsukuba

5. Medtronic, Inc

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/80/8/80_CJ-16-0285/_pdf

Reference17 articles.

1. 1. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1–e76, doi:10.1016/j.jacc.2014.03.022.

2. 2. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 2011; 13: 1110–1117.

3. 3. Ohlmeier C, Mikolajczyk R, Haverkamp W, Garbe E. Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans. Europace 2013; 15: 1437–1444.

4. 4. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination. Int J Cardiol 2009; 137: 102–107.

5. 5. Packer DL, Kowal RC, Whelan KR, Irwin JM, Champagne J, Guerra PG, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: First results of the North American Arctic Front (STOP AF) Pivotal Trial. J Am Coll Cardiol 2013; 61: 1713–1723.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, efficacy, and quality of life outcomes of pulsed field ablation in Japanese patients with atrial fibrillation: results from the PULSED AF trial;Journal of Interventional Cardiac Electrophysiology;2024-09-07

2. A systematic literature review of Real-World Evidence (RWE) on post-market assessment of medical devices;2023-03-02

3. Initial multicenter clinical experience with the first-generation endoscopic guided laser balloon in Japan;Journal of Interventional Cardiac Electrophysiology;2023-02-11

4. HotBalloon Pulmonary Vein Isolation Registry Study　― Real-World Efficacy and Safety of HotBalloon Ablation ―;Circulation Journal;2022-12-23

5. Cryoballoon ablation for paroxysmal atrial fibrillation in Japan: 2-year safety and efficacy results from the Cryo AF Global Registry;Journal of Interventional Cardiac Electrophysiology;2022-02-04